| Ex. FED-099 | CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020)QSO-20-20-ALL, Prioritization of Survey Activities | CMS, Quality, Safety & Oversight Group | Mar. 23, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Names this instrument in its effective or end text |
| Ex. DUT-FED-024 | 42 C.F.R. 482.42 (hospital infection prevention and control and antibiotic stewardship programs; COVID-19 reporting)§ 482.42 Condition of participation: Infection prevention and control and antibiotic stewardship programs | Centers for Medicare & Medicaid Services (hospital condition of participation) | June 17, 1986 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Cross-referenced |
| Ex. FED-157 | QSO-20-30-NH, Nursing Home Reopening Recommendations for State and Local Officials (May 18, 2020; REVISED Mar. 10, 2021; expired Mar. 10, 2021)QSO-20-30-NH, Nursing Home Reopening Recommendations for State and Local Officials | CMS, Quality, Safety & Oversight Group | May 18, 2020 | 2020 Q22020 Q32020 Q42021 Q1 | Same issuer, within ninety days |
| Ex. FED-161 | QSO-20-29-NH and CMS-5531-IFC, 85 Fed. Reg. 27550 (May 8, 2020): 42 C.F.R. 483.80(g) reportingQSO-20-29-NH | CMS, Quality, Safety & Oversight Group | May 6, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Same issuer, within ninety days |
| Ex. FED-166 | CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020)QSO-20-35-ALL | CMS, Quality, Safety & Oversight Group | Aug. 17, 2020 | 2020 Q32020 Q42021 Q12021 Q22021 Q3 | Same issuer, within ninety days |
| Ex. FED-097 | QSO-20-14-NH, Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in Nursing Homes (Mar. 9, 2020; REVISED Mar. 13, 2020)QSO-20-14-NH (REVISED) | CMS, Quality, Safety & Oversight Group | Mar. 13, 2020 | 2020 Q22020 Q3 | Same issuer, within ninety days |
| Ex. FED-098 | QSO-20-18-HHA, Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Home Health Agencies (HHAs)QSO-20-18-HHA | CMS, Quality, Safety & Oversight Group | Mar. 10, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Same issuer, within ninety days |
| Ex. FED-168 | CMS-3401-IFC, 85 Fed. Reg. 54820 (Sept. 2, 2020) (42 C.F.R. 483.80(h) testing; 482.42(e) hospital reporting) and QSO-20-38-NH (Aug. 26, 2020; revised through Sept. 23, 2022)QSO-20-38-NH (Aug. 26, 2020) | CMS, Quality, Safety & Oversight Group | Aug. 26, 2020 | 2020 Q32020 Q42021 Q12021 Q22021 Q3 | Same issuer, within ninety days |
| Ex. FED-164 | CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020)QSO-20-12-All, Suspension of Survey Activities | CMS, Quality, Safety & Oversight Group | Mar. 4, 2020 | 2020 Q2 | Same issuer, within ninety days |